Cancer HealthCast: New Technologies Lead to Major Breakthroughs in Cancer Detection, Screening at NCI
Two key programs are playing a vital role in detecting and diagnosing cancer as well as reducing the overall burden on patients and their families.
The National Cancer Institute is utilizing a host of new technologies to diagnose and detect cancer thanks to its Innovative Molecular Analysis Technologies (IMAT) and Informatics Technology for Cancer Research (ITCR) programs. These programs are developing methods that are enhancing cancer research, including artificial intelligence.
Dr. Kelly Crotty, program director for NCI’s Center for Strategic Scientific Initiatives, said not only have the programs helped researchers better identify and screen for cancer, but also they’ve been instrumental in driving progress in clinical care. Crotty also shares updates about NCI’s Liquid Biopsy Consortium and discusses the benefits and challenges she’s seeing with AI.
-
Dr. Kelly Crotty Program Director, Center for Strategic Scientific Initiatives NCI
-
Equipping the Federal Workforce for AI
Federal leaders discuss advancing AI talent development through upskilling, partnerships and responsible adoption.
20m watch -
Pentagon Memo Creates Unified Tech Enterprise for Acquisition Modernization
War Secretary names Emil Michael "single CTO" in charge of a consolidated defense innovation portfolio as the department builds a single operating system for modernization.
5m read -
Congressional Spending Deal Could Revive Technology Modernization Fund
A $1.2 trillion minibus would extend the TMF through Sept. 30, unlocking nearly $200 million and preserving momentum for federal modernization projects.
2m read -
NIST Launches ARIA to Redefine How AI Is Evaluated
NIST's ARIA aims to measure real‑world AI behavior, moving beyond accuracy scores to capture risks revealed through model testing, red‑teaming and field trials.
3m read
